After a year of testing, Alexa Plus excels at smart home control, understanding natural language and complex routines. However, its attempts at personal assistance are flawed, marred by inconsistent performance and intrusive ads, suggesting a need for Amazon to refocus on its core smart home strengths.
A poll at San Francisco Tech Week revealed significant skepticism towards Anthropic's potential $3 trillion IPO valuation, with only three attendees willing to buy shares at that price. This highlights broader market uncertainties and the high bar for AI companies seeking public market validation.
Manchester City fans grapple with serious charges of financial rule-breaking, sparking debate over club loyalty, historical memories, and the impact on the fanbase. Some feel betrayed, while others prioritize team support and cherished moments.
Former Bard College President Leon Botstein has resigned from all his positions at the institution following serious allegations of enabling and possibly participating in Jeffrey Epstein's abuse. A House Judiciary Committee letter cites a concerning email from Botstein and multiple reports of misconduct.
A groundbreaking optogenetic therapy combined with special goggles has enabled some individuals with retinitis pigmentosa to perceive light and identify objects. Seven out of ten participants showed improved light sensitivity, with four able to navigate doorways. This marks a significant step in restoring vision for degenerative eye conditions.
A recent meta-analysis indicates that vitamin D2 supplements, commonly used, might inadvertently lower the body's levels of vitamin D3, the more effective form. This raises questions about optimal supplementation strategies.
Ana Navarro expresses deep concern over RFK Jr.'s potential role at HHS, linking it to a recent plague death in Russia and emphasizing the need for qualified leadership during health crises.
New laptops featuring Nvidia's RTX Spark chip are entering the market with premium pricing, starting at $2,599 and reaching up to $7,000 for top configurations. These devices target professional creators and AI users.
A new experimental drug, CBL-514, has shown promise in eliminating dangerous visceral fat, unlike traditional weight loss methods that only shrink fat cells. Early trials indicate a significant reduction in fat surrounding internal organs, potentially mitigating risks for diabetes and heart disease.